Sofamor finally enters the US spinal cage market
This article was originally published in Clinica
Executive Summary
The US FDA last week told Sofamor Danek that it could finally begin selling its first spinal fusion cage product in the US, nearly 18 months after its first application to sell the device had been turned down.